Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2015
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 22 Dec 2015 New trial record